相关实验视频

Updated: May 7, 2025

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

在患有 status epilepticus 的老年患者中,安培/苏尔巴克坦使发作恶化

Kaoru Obata^1,2, Masako Kinoshita³, Akiyo Shinde¹

¹Department of Neurology, Tenri Hospital, Tenri, Nara, Japan.

International journal of emergency medicine

|January 3, 2025

概括

西林/苏尔巴克坦 (ABPC/SBT) 可能会使发作恶化在患者的状态. 这项案例研究发现,ABPC/SBT的使用增加了发作的频率和持续时间,强调需要仔细监测.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.
关键护理医学关键护理医学

背景情况:

状态 (SE) 是一种神经紧急情况,通常因吸气性肺炎而复杂.
西林/苏尔巴克坦 (ABPC/SBT) 是一种常见的抗生素,用于吸入性肺炎,属于β-lactam类,已知可能加剧发作.
在SE患者中,ABPC/SBT对活动的影响需要进行研究.

研究的目的:

调查安培/苏尔巴克坦 (ABPC/SBT) 给药是否会使发作在患有 status epilepticus 的患者中恶化.
评估电脑电图 (EEG) 监测在评估发作严重程度和识别致病因素方面的有用性.

主要方法:

一个84岁的男性病例报告,患有状态和吸入性肺炎.
使用连续视频EEG监测来跟踪活动.
分析了发作的频率和持续时间,分别是10次ABPC/SBT治疗前后几个小时.

主要成果:

服用ABPC/SBT导致发作频率显著增加 (3.2至7.3次每2小时,p=0.047).
在ABPC/SBT给药后观察到增加发作持续时间的趋势 (199年至406年,p=0.079).
脑电图趋势图分析将ABPC/SBT给药与活动增加相关联.

结论:

在这种患有状况的患者中,安培/苏尔巴克坦 (ABPC/SBT) 的使用与发作恶化有关.
脑电图监测,特别是趋势图分析,是评估发作严重程度和危急病患者潜在恶化的因素的宝贵工具.

关键词:

西林 / 苏尔巴克塔姆.抗生素相关的脑病变与抗生素相关的脑病变持续的脑电图监测持续的脑电图监测关键的护理电脑电脑电脑电脑.密度光谱阵列是一个密度光谱阵列.发作恶化发作恶化状态性病的状态

更多相关视频

Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings

Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings

Published on: May 7, 2020

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

相关概念视频

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Arteries of the Lower Limbs

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

Depolarizing Blockers: Pharmocokinetics

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...